Promising development in understanding of HER2 cancers

July 18, 2010

Scientists in Edinburgh, Scotland, have discovered a gene which causes certain HER2 cancers (those producing a protein named human epidermal growth factor receptor 2) to grow. Current treatment for HER2 breast cancer includes medicines which target the protein HER2, like Herceptin (trastuzumab). These treatments don’t always work, so a new treatment would be important.

The new research indicates that a protein called C35 promotes the development and spreading of breast cancer. This protein provides a target for potential new treatments suitable for certain breast cancer patients. The study was published in the British Journal of Cancer (e-publication date 13 July 2010).

The Daily Telegraph reports that a new treatment to stop HER2 cancer from spreading around the body is in the early stages of development.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: